Literature DB >> 28572227

Medical problems in pregnancy.

Bhaskar Narayan1, Catherine Nelson-Piercy2.   

Abstract

The prevalence of medical problems in pregnancy is increasing because of a complex interplay between demographic and lifestyle factors, and developments in modern medicine. Maternal mortality and morbidity resulting from treatable medical conditions, such as venous thromboembolism, epilepsy and autoimmune disease, have not decreased in recent years. This is despite a marked decrease in overall maternal mortality. It is vital that all physicians acquire a basic knowledge and understanding of medical problems in pregnancy. This includes prepregnancy measures such as counselling and optimisation of medical therapy, as well as multidisciplinary management throughout pregnancy and the postpartum period. Prompt recognition and treatment of acute and chronic illness is of clear benefit, and most drugs and many radiological investigations may be used in pregnancy. © Royal College of Physicians 2017. All rights reserved.

Entities:  

Keywords:  Biologics; maternal mortality; obstetric medicine; pregnancy

Mesh:

Year:  2017        PMID: 28572227      PMCID: PMC6297557          DOI: 10.7861/clinmedicine.17-3-251

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  22 in total

Review 1.  Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis.

Authors:  Alexander Marchenko; Fatma Etwel; Olukayode Olutunfese; Cheri Nickel; Gideon Koren; Irena Nulman
Journal:  Headache       Date:  2015-02-03       Impact factor: 5.887

2.  SUDEP and epilepsy-related mortality in pregnancy.

Authors:  Stephan Edey; Nicholas Moran; Lina Nashef
Journal:  Epilepsia       Date:  2014-04-22       Impact factor: 5.864

3.  Headache in United States emergency departments: demographics, work-up and frequency of pathological diagnoses.

Authors:  J N Goldstein; C A Camargo; A J Pelletier; J A Edlow
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

4.  Corticosteroid use during pregnancy and risk of orofacial clefts.

Authors:  Anders Hviid; Ditte Mølgaard-Nielsen
Journal:  CMAJ       Date:  2011-04-11       Impact factor: 8.262

Review 5.  High-risk pregnancy and the rheumatologist.

Authors:  May Ching Soh; Catherine Nelson-Piercy
Journal:  Rheumatology (Oxford)       Date:  2014-12-03       Impact factor: 7.580

6.  Reversible cerebral vasoconstriction syndrome: a rare cause of postpartum headache.

Authors:  Kate S Wiles; Ross Nortley; Ata Siddiqui; Paul Holmes; Catherine Nelson-Piercy
Journal:  Pract Neurol       Date:  2015-01-08

7.  Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.

Authors:  Sara A Ephross; Susan M Sinclair
Journal:  Headache       Date:  2014-05-07       Impact factor: 5.887

8.  Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.

Authors:  Bindia Jharap; Nanne K H de Boer; Pieter Stokkers; Daniel W Hommes; Bas Oldenburg; Gerard Dijkstra; C Janneke van der Woude; Dirk J de Jong; Chris J J Mulder; Ruurd M van Elburg; Adriaan A van Bodegraven
Journal:  Gut       Date:  2013-02-19       Impact factor: 23.059

9.  Fertility in women with rheumatoid arthritis: influence of disease activity and medication.

Authors:  Jenny Brouwer; Johanna M W Hazes; Joop S E Laven; Radboud J E M Dolhain
Journal:  Ann Rheum Dis       Date:  2014-05-15       Impact factor: 19.103

Review 10.  Safety of TNF-α inhibitors during IBD pregnancy: a systematic review.

Authors:  Ole Haagen Nielsen; Edward V Loftus; Tine Jess
Journal:  BMC Med       Date:  2013-07-31       Impact factor: 8.775

View more
  10 in total

1.  Medical problems in pregnancy.

Authors:  Irina Stoian; Bridget MacDonald
Journal:  Clin Med (Lond)       Date:  2017-12       Impact factor: 2.659

2.  Medical problems in pregnancy.

Authors:  Ritesh Sah; Shahid A Kausar
Journal:  Clin Med (Lond)       Date:  2017-12       Impact factor: 2.659

3.  Medical problems in pregnancy.

Authors:  Bhaskar Narayan; Sheba Jarvis; Pooja Dassan; Catherine Nelson-Piercy
Journal:  Clin Med (Lond)       Date:  2018-02       Impact factor: 2.659

4.  Remote multimodality monitoring of maternal physiology from the first trimester to postpartum period: study results.

Authors:  Agata P Zielinska; Edward Mullins; Elena Magni; Giulia Zamagni; Hana Kleprlikova; Olive Adams; Tamara Stampalija; Lorenzo Monasta; Christoph Lees
Journal:  J Hypertens       Date:  2022-08-12       Impact factor: 4.776

5.  Pregnancy complications in Brazilian puerperal women treated in the public and private health systems.

Authors:  Patrícia Louise Rodrigues Varela; Rosana Rosseto de Oliveira; Emiliana Cristina Melo; Thais Aidar de Freitas Mathias
Journal:  Rev Lat Am Enfermagem       Date:  2018-01-08

6.  The impact of lower urinary tract symptoms on the quality of life during pregnancy: a cross-sectional study from Palestine.

Authors:  Qais T Ahmad; Jaffar H Saffarini; Ahmad M Samara; Dima S Jabri; Zaina H Safarini; Yousra M Banijaber; Ahmad Jaradat; Faris Abushamma; Sa'ed H Zyoud
Journal:  BMC Urol       Date:  2020-12-04       Impact factor: 2.264

7.  Nosocomial COVID-19 infection in women undergoing elective cesarean delivery: a prospective cohort study.

Authors:  Aaron Nizam; Michael L Nimaroff; Andrew W Menzin; Gary L Goldberg; Santiago J Miyara; Ernesto Molmenti
Journal:  Am J Obstet Gynecol MFM       Date:  2021-09-17

Review 8.  Epilepsy in Pregnancy-Management Principles and Focus on Valproate.

Authors:  Barbara Błaszczyk; Barbara Miziak; Ryszard Pluta; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

9.  Anti N-methyl-D-aspartate receptor (NMDAr) encephalitis during pregnancy: A case report.

Authors:  Fedele Dono; Giacomo Evangelista; Stefano Consoli; Giovanna Scorrano; Mirella Russo; Martina di Pietro; Marco Onofrj; Stefano L Sensi; Francesca Anzellotti
Journal:  Epilepsy Behav Rep       Date:  2022-03-19

10.  Adherence with blood pressure self-monitoring in women with pregnancy hypertension, and comparisons to clinic readings: A secondary analysis of OPTIMUM-BP.

Authors:  Liza Bowen; Louise Pealing; Katherine Tucker; Richard J McManus; Lucy C Chappell
Journal:  Pregnancy Hypertens       Date:  2021-05-28       Impact factor: 2.899

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.